AIGP Health

AIGP Health, founded by clinicians including Dr.

Reviewed by 7wData
Share Email

On this page

Profile

AI platform that automates clinical workflows like patient intake, documentation, and follow-up for healthcare providers.

AIGP Health, founded by clinicians including Dr. Anindita Santosa (CEO), Dr. Nicholas Chia, Dr.

Prateet Singh, and Dr. Yudara Kularathne, is a Singapore-based healthcare AI company focused on agentic AI for clinical workflows. The company's flagship product, Anzu, is designed to automate and orchestrate patient journeys—from intake to follow-up—while maintaining clinician oversight.

AIGP targets the growing strain on healthcare systems, particularly in Asia-Pacific, where aging populations and chronic disease burdens are escalating. The platform claims to save clinicians 15+ minutes per consultation and increase patient engagement by 40%, with SOC 2 Type II and HSA Class A certifications underscoring its compliance focus. Its multilingual support (English, Malay, Chinese, Tamil, Bahasa Indonesia) and integration with WhatsApp and web platforms aim to reduce adoption friction.

The company emphasizes clinical accuracy (95% claimed) and specializes in complex care domains like rheumatology, where its IntelliRheum product addresses diagnostic delays and longitudinal data synthesis. AIGP's white papers highlight a clinician-driven approach, though its financials and customer traction remain undisclosed in public filings.

Track AIGP Health and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Primary care clinics facing administrative overload
  • Specialist practices (e.g., rheumatology, immunology) managing complex cases
  • Healthcare systems in Asia-Pacific addressing multilingual patient populations
  • Chronic care providers needing automated follow-up tools
  • Outpatient facilities seeking EHR-integrated scribing solutions

Strengths and what to watch

Strengths

  • Clinician-founded team with deep domain expertise in rheumatology and complex care
  • SOC 2 Type II and HSA Class A certifications for regulated healthcare deployments
  • Multilingual support and WhatsApp integration reduce adoption barriers in target markets

Watch for

  • Unclear revenue model or pricing transparency for scaled deployments
  • Dependence on WhatsApp as a channel raises data sovereignty questions in some regions
  • Specialist focus (e.g., rheumatology) may limit broad-market appeal without proven horizontal scalability

Key Information

Founded
2024
Headquarters
Singapore

Frequently Asked Questions

What is AIGP Health?

AIGP Health is a Singapore-based AI platform automating clinical workflows like patient intake, documentation, and follow-up. Founded by clinicians, its flagship product Anzu orchestrates patient journeys while maintaining clinician oversight. The platform targets healthcare providers in Asia-Pacific, offering multilingual support and WhatsApp integration to reduce administrative burdens.

How does AIGP Health improve clinical workflows?

AIGP Health's AI platform saves clinicians 15+ minutes per consultation by automating documentation and patient communication. It increases engagement by 40% through multilingual support (English, Malay, Chinese, etc.) and WhatsApp integration. The system maintains 95% clinical accuracy while handling complex workflows in specialties like rheumatology.

Is AIGP Health compliant with healthcare regulations?

Yes, AIGP Health holds SOC 2 Type II and HSA Class A certifications, meeting stringent healthcare compliance standards. These validate its data security and operational controls for handling sensitive patient information. The platform is designed for regulated environments, particularly in Asia-Pacific healthcare systems.

Which healthcare providers use AIGP Health?

AIGP Health serves primary care clinics, specialist practices (rheumatology/immunology), and chronic care providers in Asia-Pacific. Its solutions target facilities needing EHR-integrated scribing, multilingual patient engagement, or automated follow-ups. The IntelliRheum product specifically addresses diagnostic delays in rheumatology practices.

What languages does AIGP Health support?

AIGP Health offers multilingual support for English, Malay, Chinese, Tamil, and Bahasa Indonesia. This facilitates patient communication across diverse Asia-Pacific populations. The platform integrates with WhatsApp and web interfaces to reduce adoption barriers in regions where these channels dominate healthcare interactions.

What are the limitations of AIGP Health?

AIGP Health's specialist focus may limit broad adoption beyond complex care domains like rheumatology. Its reliance on WhatsApp raises data sovereignty concerns in some regions. Pricing transparency for large deployments remains unclear, and horizontal scalability across general practice isn't yet proven beyond its core specialties.

Sources

  1. www.aigp.health — Product capabilities, certifications, and leadership
  2. www.aigp.health — Founding team, clinical focus, and market context
  3. www.aigp.health — Specialization in rheumatology and agentic AI differentiation
  4. www.prnewswire.com — Industry context for AI in biotech (indirect)